AVNS

AVANOS MEDICAL, INC.

AVNS · CIK 1606498 · Annual (10-K) · Last 8 years

Financial Trends

Revenue$701M
20182025
Net Income−$73M
20182025
Operating CF$75M
20182025
Free Cash Flow
20182025

Income Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Revenue$0.7B$0.7B$0.7B$0.8B$0.7B$0.7B$0.7B$0.7B
Cost of Revenue$0.3B$0.3B$0.3B$0.4B$0.4B$0.3B$0.3B$0.3B
Gross Profit$0.4B$0.4B$0.4B$0.5B$0.4B$0.4B$0.4B$0.4B
R&D Expense$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
SG&A Expense$0.3B$0.3B$0.3B$0.3B$0.3B$0.3B$0.4B$0.3B
Operating Income$-0.1B$-0.4B$0.0B$0.1B$0.0B$-0.0B$-0.1B$0.0B
Net Income$-0.1B$-0.4B$-0.1B$0.1B$0.0B$-0.0B$-0.0B$0.1B
EPS (Basic)$-1.57$-8.53$-1.32$1.08$0.11$-0.57$-0.96$1.22
EPS (Diluted)$-1.57$-8.53$-1.32$1.07$0.11$-0.57$-0.96$1.22

Balance Sheet

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Total Assets$1.1B$1.2B$1.7B$1.8B$1.6B$1.7B$1.8B$1.8B
Current Assets$0.4B$0.4B$0.5B$0.5B$0.4B$0.5B$0.5B$0.7B
Cash & Equivalents$0.1B$0.1B$0.1B$0.1B$0.1B$0.1B$0.2B$0.4B
Total Liabilities$0.3B$0.3B$0.5B$0.5B$0.3B$0.4B$0.5B$0.5B
Current Liabilities$0.2B$0.2B$0.2B$0.2B$0.1B$0.2B$0.2B$0.3B
Stockholders' Equity$0.8B$0.8B$1.2B$1.3B$1.3B$1.3B$1.3B$1.3B

Cash Flow Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Operating Cash Flow$0.1B$0.1B$0.0B$0.1B$0.1B$-0.0B$-0.1B$-0.1B
Investing Cash Flow$-0.1B$-0.0B$0.0B$-0.1B$-0.0B$-0.0B$-0.1B$0.6B
Capital Expenditures————————
Financing Cash Flow$-0.0B$-0.0B$-0.1B$0.1B$-0.1B$-0.1B$0.0B$-0.3B
← Companies